Profile
Sector:
Consumer DefensiveIndustry:
Household & Personal ProductsCountry:
United StatesIPO:
23 September 2021Website:
http://www.carmellrx.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 12 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
What sector is Carmell Therapeutics Corporatio in?
Carmell Therapeutics Corporatio is in the Consumer Defensive sector
What industry is Carmell Therapeutics Corporatio in?
Carmell Therapeutics Corporatio is in the Household & Personal Products industry
What country is Carmell Therapeutics Corporatio from?
Carmell Therapeutics Corporatio is headquartered in United States
When did Carmell Therapeutics Corporatio go public?
Carmell Therapeutics Corporatio initial public offering (IPO) was on 23 September 2021
What is Carmell Therapeutics Corporatio website?
https://www.carmellrx.com
Is Carmell Therapeutics Corporatio in the S&P 500?
No, Carmell Therapeutics Corporatio is not included in the S&P 500 index
Is Carmell Therapeutics Corporatio in the NASDAQ 100?
No, Carmell Therapeutics Corporatio is not included in the NASDAQ 100 index
Is Carmell Therapeutics Corporatio in the Dow Jones?
No, Carmell Therapeutics Corporatio is not included in the Dow Jones index
When does Carmell Therapeutics Corporatio report earnings?
The next expected earnings date for Carmell Therapeutics Corporatio is 14 August 2024